Loan Agreement between FID Esprit AG Rosengartenstrasse 4 CH-8608 Bubikon Represented by Axel Kutscher (subsequently „FID Esprit”) and Sangui BioTech International, Inc. Alfred-Herrhausen-Str.44 58455 Witten Represented by Prof. Wolfgang Barnikol...
Exhibit
99.2
between
FID
Esprit AG
Xxxxxxxxxxxxxxxxxx
0
XX-0000
Xxxxxxx
Represented
by Xxxx Xxxxxxxx (subsequently „FID Esprit”)
and
Sangui
BioTech International, Inc.
Xxxxxx-Herrhausen-Str.44
58455
Witten
Represented
by Xxxx. Xxxxxxxx Xxxxxxxx (President and CEO) and Xx. Xxxxxxx Fleing (Director)
(Subsequently „Sangui”)
1. Background
Sangui
intends to expand its cosmetics business by establishing its own internet shop
and related advertizing.
FID
Esprit is ready and willing to support this venture by offering a
loan.
2. Amount
of
Loan
FID
Esprit will provide €40,000.00 to Sangui in one or more installments between
April 5, 2006 and May 31, 2006. The loan shall be sent by wire
transfer to Sangui account No. XXXX at Stadtsparkasse Xxxxxx.
3. Interest
and amortization
The
loan
will bear interest of 6% p.a. effective of the date of receipt of the
loan.
Amortization
and interest will be redeemed as of June 30, 2007 at the
latest. Sangui is entitled to redeem the loan either in cash or by
providing shares of common stock, valued at 50% of the average Hamburg OTC
trading price of Sangui’s stock over the four weeks preceding the
redemption.
4. Risk
advice
Feedback
has been instructed and understands that Sangui’s current business and financial
situation offers raises significatn doubt that Sangui will continue as a going
concern. Feedback knows that there is no assurance that the loan
might not be lost althogeether eventually.
5. Severability
Clause
If
any
term or condition of this Agreement is null and void or will become null and
void during its course, then the validity and effectiveness of all other terms
and conditions shall not be imparied thereby.
6. Changes
of Agreement
Changes
and amendments of this Agreement will not be valid unless in writing and signed
by both parties.
Bubikon,
April 4,
2006
Witten, July 4, 2006
/s/
Xxxx
Xxxxxxxx
/s/ Xxxx. Xxxxxxxx Xxxxxxxx
________________________
________________________
Xxxx
Xxxxxxxx Xxxx.
Xxxxxxxx Xxxxxxxx
FID
Esprit
AG Sangui
BioTech International, Inc.
/s/ Xx. Xxxxxxx Fleing
________________________
Xx.
Xxxxxxx Fleing
Sangui
BioTech International, Inc.
